Simultaneous Infiltration of Polyfunctional Effector and Suppressor T Cells into Renal Cell Carcinomas

被引:71
作者
Attig, Sebastian [1 ]
Hennenlotter, Joerg [2 ]
Pawelec, Graham [3 ]
Klein, Gerd [4 ]
Koch, Sven D. [6 ]
Pircher, Hanspeter [7 ]
Feyerabend, Susan [2 ]
Wernet, Dorothee [5 ]
Stenzl, Arnulf [2 ]
Rammensee, Hans-Georg [1 ]
Gouttefangeas, Cecile [1 ]
机构
[1] Univ Tubingen, Dept Immunol, Inst Cell Biol, D-72076 Tubingen, Germany
[2] Univ Tubingen Hosp, Urol Clin, Tubingen, Germany
[3] Univ Tubingen Hosp, Tubingen Aging & Tumor Immunol Grp, Sect Transplantat Immunol & Immunohematol, Tubingen, Germany
[4] Univ Tubingen Hosp, Med Res Ctr, Sect Transplantat Immunol & Immunohematol, Tubingen, Germany
[5] Univ Tubingen Hosp, Dept Transfus Med, Tubingen, Germany
[6] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands
[7] Univ Freiburg, Dept Immunol, Freiburg, Germany
关键词
IMMUNE SUPPRESSION; METASTATIC MELANOMA; LYMPHOCYTES; EXPRESSION; MEMORY; CD4+; INTERLEUKIN-10; POLARIZATION; RECRUITMENT; GENERATION;
D O I
10.1158/0008-5472.CAN-09-0852
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Renal cell carcinoma is frequently infiltrated by cells of the immune system. This makes it important to understand interactions between cancer cells and immune cells so they can be manipulated to bring clinical benefit. Here, we analyze subsets and functions of T lymphocytes infiltrating renal cell tumors directly ex vivo following mechanical disaggregation and without any culture step. Subpopulations of memory and effector CD4(+) Th1, Th2, and Th17 and CD8(+) Tc1 cells were identified based on surface phenotype, activation potential, and multicytokine production. Compared with the same patient's peripheral blood, T lymphocytes present inside tumors were found to be enriched in functional CD4(+) cells of the Th1 lineage and in effector memory CD8(+) cells. Additionally, several populations of CD4(+) and CD8(+) regulatory T cells were identified that may synergize to locally dampen antitumor T-cell responses. [Cancer Res 2009;69(21):8412-9]
引用
收藏
页码:8412 / 8419
页数:8
相关论文
共 50 条
[1]  
Angevin E, 1997, INT J CANCER, V72, P431, DOI 10.1002/(SICI)1097-0215(19970729)72:3<431::AID-IJC10>3.3.CO
[2]  
2-3
[3]   Phenotype and Function of Human T Lymphocyte Subsets: Consensus and Issues [J].
Appay, Victor ;
van Lier, Rene A. W. ;
Sallusto, Federica ;
Roederer, Mario .
CYTOMETRY PART A, 2008, 73A (11) :975-983
[4]   Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation [J].
Casazza, Joseph P. ;
Betts, Michael R. ;
Price, David A. ;
Precopio, Melissa L. ;
Ruff, Laura E. ;
Brenchley, Jason M. ;
Hill, Brenna J. ;
Roederer, Mario ;
Douek, Daniel C. ;
Koup, Richard A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (13) :2865-2877
[5]   Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma [J].
Cesana, GC ;
DeRaffele, G ;
Cohen, S ;
Moroziewicz, D ;
Mitcham, J ;
Stoutenburg, J ;
Cheung, K ;
Hesdorffer, C ;
Kim-Schulze, S ;
Kaufman, HL .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) :1169-1177
[6]   Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas [J].
Cózar, J ;
Canton, J ;
Tallada, M ;
Concha, A ;
Cabrera, T ;
Garrido, F ;
Osuna, FRC .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (09) :858-866
[7]   Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival [J].
Curiel, TJ ;
Coukos, G ;
Zou, LH ;
Alvarez, X ;
Cheng, P ;
Mottram, P ;
Evdemon-Hogan, M ;
Conejo-Garcia, JR ;
Zhang, L ;
Burow, M ;
Zhu, Y ;
Wei, S ;
Kryczek, I ;
Daniel, B ;
Gordon, A ;
Myers, L ;
Lackner, A ;
Disis, ML ;
Knutson, KL ;
Chen, LP ;
Zou, WP .
NATURE MEDICINE, 2004, 10 (09) :942-949
[8]   Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas [J].
Dengjel, Jorn ;
Nastke, Maria-Dorothea ;
Gouttefangeas, Cecile ;
Gitsioudis, Gitsios ;
Schoor, Oliver ;
Altenberend, Florian ;
Mueller, Margret ;
Kraemer, Bjoern ;
Missiou, Anna ;
Sauter, Martina ;
Hennenlotter, Joerg ;
Wernet, Dorothee ;
Stenzl, Arnulf ;
Rammensee, Hans-Georg ;
Klingel, Karin ;
Stevanovic, Stefan .
CLINICAL CANCER RESEARCH, 2006, 12 (14) :4163-4170
[9]   Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients [J].
Finke, James H. ;
Rini, Brian ;
Ireland, Joanna ;
Rayman, Patricia ;
Richmond, Amy ;
Golshayan, Ali ;
Wood, Laura ;
Elson, Paul ;
Garcia, Jorge ;
Dreicer, Robert ;
Bukowski, Ronald .
CLINICAL CANCER RESEARCH, 2008, 14 (20) :6674-6682
[10]  
Finke JH, 2001, CLIN CANCER RES, V7, p940S